BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04924101-completion@plaintrial.com
DTSTAMP:20261029T013854Z
DTSTART;VALUE=DATE:20250623
SUMMARY:Efficacy and Safety of Pembrolizumab Plus Investigational Agents in
  Combination With Chemotherapy as First-Line Treatment in Extensive-Stage 
 Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) — estimated 
 completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04924101
URL:https://plaintrial.com/trial/NCT04924101
END:VEVENT
END:VCALENDAR